Avoiding Heart Disease

Related topics:heart, Blood Press , Calor , Cigarettes , Circulation System , Coronary Arteries , Diabetes , Dietitian , Drin , Hea , heart disease , High Blood Pressure , Incr , Medical Circles , medication , Mid Section , Ov , Registe , Target Weight , Two Pounds , Weight Goal , Enter your search termsSubmit search form digghealth.com WebAccording to statistics providd by the

Wellbutrin, A Controversial Stop-Smoking Medication

One in five adults in the US, or nearly 45 million people, smoke. Smoking is one of the leading causes of preventable deaths. Smoking causes 1 out of 5 deaths in the US each year, with smoking killing close to 500,000 Americans a year, and over 1,000 a day. Cigarette smoking is responsible for a growing list of cancers, as well as chronic diseases including those of the lung and heart. It also has horrid health effects such as hair loss, tooth decay and premature aging. If you’ve decided

Wellbutrin, A Controversial Stop-Smoking Medication

Wellbutrin, A Controversial Stop-Smoking Medication One in five adults in the US, or nearly 45 million people, smoke. Smoking is one of the leading causes of preventable deaths. Smoking causes 1 out of 5 deaths in the US each year, with smoking killing close to 500,000 Americans a year, and over 1,000 a day. Cigarette smoking is responsible for a growing list of cancers, as well as chronic diseases including those of the lung and heart. It also has horrid health effects such as hair

Read the report on Singulair

561. (RI) - June 12, 2008 Read the report on Singulair ASK THE PHARMACIST Read the report on Singulair Question: I usually start taking Singulair Ž for my allergies around this time of year. Should I opt for something else since the recent reports of increased suicide with this drug? Answer: Singulair Ž , or montelukast is a widely used medication for the treatment of asthma or allergic rhinitis. Patients tend to prefer it because it is oral and not inhaled, like many asthma and a

Advair inhaled asthma drug, the first treatment to combine the two most popular types of asthma medication

31. The News Observer - August 26, 2000 Glaxo gets FDA go-ahead to sell its new asthma drug RESEARCH TRIANGLE PARK — Glaxo Wellcome won U. S. Food and Drug Administration approval to sell its Advair inhaled asthma drug, the first treatment to combine the two most popular types of asthma medication. The approval for Advair, which is expected to post blockbuster sales, was announced a day after the FDA announced that it had ordered Glaxo to attach to every bottle of its Lotronex medic

Next Page »